Who We Are
Trial Equity is a health technology and consulting company focused on improving patient recruitment, retention, and engagement in clinical trials. We offer digital learning solutions, public education campaigns, and operational consulting services that empower pharmaceutical companies, CROs, and research sites to enroll and retain patients more effectively. Our products include interactive eLearning courses, community-focused disease education programs, and ESG consulting.
Meet the Founders Behind Trial Equity’s Mission
At Trial Equity, we believe that transforming clinical trials starts with the right expertise—rooted in science, strengthened by experience, and driven by a commitment to better outcomes for all patients. Our founders bring decades of leadership in clinical research, training, and product development to deliver the innovative solutions our clients rely on.
Ashni Niemeyer, MSc, B. Eng
Chief Operating Officer & Head of Product Development
​
Ashni Niemeyer is an experienced product strategist and corporate learning expert with a background in engineering and international business. Her career spans over 15 years leading enterprise training, knowledge management, and employee engagement initiatives across global organizations.
​
A double-certified trainer and credentialed knowledge manager, Ashni has developed award-winning learning programs and operational frameworks that drive performance and innovation. Her leadership roles in training strategy and organizational change have shaped her approach to delivering scalable, user-focused solutions in complex environments.
​
At Trial Equity, Ashni leads the development of our interactive eLearning courses, proprietary learning management system (LMS), and community education tools. She ensures that each product delivers an intuitive and impactful learning experience—whether it’s training clinical site staff, upskilling CRAs, or educating patients about clinical trials.
Her ability to integrate technology, learning science, and real-world user needs has been critical in shaping Trial Equity’s product portfolio to support recruitment, retention, and engagement in clinical trials.
Otis Johnson, PhD, MPA
Co-founder & Principal Consultant
​
Dr. Otis Johnson is a leading authority in clinical trial strategy and patient-centered research innovation. With over 20 years in the pharmaceutical industry—including 13 years at Merck and executive leadership roles at Syneos Health, ICON, and Clario—Dr. Johnson brings unmatched depth in both the scientific and operational aspects of drug development.
​
He played a pivotal role in launching and scaling Clario’s Trial Oversight analytics platform into a $30 million business, demonstrating his ability to turn vision into value. As Chief Diversity, Inclusion and Sustainability Officer at Clario, he launched strategic initiatives that improved research access and organizational performance, earning accolades such as the 2024 HBA Honorable Mentor Award and one of PharmaVoice’s 100 Most Inspiring Industry Leaders.
At Trial Equity, Dr. Johnson leads the development and delivery of ESG consulting services. He also plays a key role in shaping our cultural competency training solutions, supporting sites and trial teams in engaging underrepresented patient populations.